Abcam, ab259038, Human PHF23 knockout HEK-293T cell lysate

Size: 1Kit
PHF23 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2.
Key facts
Cell type:HEK-293T,
Species or organism:Human,
Tissue:Kidney,
Knockout validation:Sanger Sequencing,
Mutation description:Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2.

Product details:
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation:
Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10).
This means that the protein of interest is denatured.
If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions:
Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our
limited use license
patent pages

Properties and Storage Information:
Gene name-PHF23, Gene editing type-Knockout, Gene editing method-CRISPR technology, Knockout validation-Sanger Sequencing, Zygosity-Homozygous, Shipped at conditions-Ambient - Can Ship with Ice, Appropriate short-term storage conditions--20°C, Appropriate long-term storage conditions--20°C

Supplementary Information:
This supplementary information is collated from multiple sources and compiled automatically.
PHF23 also known as Plant Homeodomain Finger 23 is a protein involved in chromatin dynamics and regulation of gene expression. It has a molecular mass of approximately 43 kDa. PHF23 contains a zinc finger domain which is important for its role in binding to histones. The protein expresses in various tissues but shows higher expression levels in certain organs like the brain and testes. Its expression pattern suggests an involvement in critical regulatory processes.
Biological function summary
PHF23 plays a role in the modification of chromatin structure influencing gene transcription. The protein participates in the formation of a complex that is involved in transcriptional repression. It particularly associates with components of the nucleosome acting as a mediator in processes that alter the accessibility of DNA for transcription factors and enzymes. The protein's ability to bind to chromatin allows it to directly impact the epigenetic state of cells.
Pathways
PHF23 is a part of the chromatin remodeling pathway and is involved in the regulation of gene transcription. Its interaction with methylated histones connects it to the pathway of histone modification. It works alongside other proteins like LSD1 which is a lysine-specific demethylase and this collaborative function influences the transcriptional output of the cell. The protein’s actions contribute to maintaining the balance between gene activation and repression which is essential for normal cellular functions.
PHF23 relates to conditions involving abnormal chromatin remodeling such as certain cancers. Its alteration affects the typical transcriptional control which can lead to tumorigenesis. The protein interacts with other proteins including members of the histone demethylase family like KDM1A influencing pathways that become dysregulated in cancerous states. Studies suggest that understanding PHF23's exact role offers potential therapeutic targets for diseases where chromatin misregulation plays an important role.